Introduction. Turner syndrome (TS) is the form of gonadal malfunction. Arterial hypertension, elevated LDL and glucose and decreased HDL levels are characteristic of TS-women. Hormone therapy is a treatment for short stature and sex hormone deficits. Hormonal replacement therapy (HRT) reduces the risk of cardiovascular diseases. A large percentage of TS-women do not comply with doctors' orders regarding HRT. The analysis of 17b estradiol(E 2 ) levels and the assessment of blood pressure, lipid and carbohydrate metabolisms in TS-women it is possible to state whether HRT decreases the risk of cardiovascular diseases? Material and methods. The group of 95 TS-women, who declared HRT, were investigated. The information about HRT was collected during the anamnesis. E 2 , total cholesterol (TC), high (HDL) and low (LDL) density lipoproteins, triglycerides (TG) and glucose were assessed. Patients were divided into subgroups with E 2 ≥ 110 pmol/L (n = 34) (HE) and < 110 pmol/L (n = 61) (LE) respectively. Results. Arterial hypertension was diagnosed in 26.3%. The groups did not differ in systolic 119 ± 20 versus 118 ± 14 and diastolic 82 ± 13 versus 80 ± 10 mm Hg blood pressure. Despite the higher concentrations of E 2 in HE, no differences were found in weights, lipids and glucose concentrations. Negative correlations between E 2 and body mass (r = -0.25, p = 0.04) and diastolic blood pressure (r = -0.28, p = 0.02) as well as positive between E 2 and glucose (r = 0.24, p < 0.05) were observed only in HE. No correlations between E 2 and lipids were found. Conclusions. 1. Only 1/3 TS-women, who declare HRT, have a satisfactory level of E 2 . 2. In TS-women HRT does not affect glucose and lipid metabolisms. 3. Negative correlation between E 2 and diastolic blood pressure in TS-women suggest beneficial effect of estrogens in hypertension.